• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PER

PERCHERON THERAPEUTICS LIMITED - Charts / Financials

0.00% ! 0.8¢
Market Cap $8.699M  !
Healthcare Biotechnology
Add to My Watchlist

Percheron Therapeutics Limited, formerly Antisense Therapeutics Limited, is a... Percheron Therapeutics Limited, formerly Antisense Therapeutics Limited, is a biotechnology company. The Company is engaged in developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The Company’s products include ATL1102 for Duchenne muscular dystrophy (DMD), ATL1103 for Acromegaly, and ATL1102 for Multiple Sclerosis (MS). ATL1102, is an antisense inhibitor targeting very late antigen 4 (VLA-4), an immune cell molecule. ATL1103 is a second-generation antisense drug designed to block growth hormone receptor (GHr) expression thereby reducing levels of the hormone insulin-like growth factor-I (IGF-I) in the blood and is a potential treatment for diseases associated with excessive growth hormone action. By inhibiting GHr production, ATL1103 in turn reduces IGF-I levels in the blood (serum). The Company is conducting a Phase II clinical trial of ATL1102 in DMD patients.More

refresh Created with Sketch. REFRESH
Day
Open 0.9¢   Day High 0.9¢   Day Low 0.8¢
Daily Volume 156476
Bids   Sellers
Number Price Volume   Number Price Volume
27 0.8¢ 6745374   6 0.9¢ 1257781

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $8.699M
Open High Low Value Volume
0.9¢ 0.9¢ 0.8¢ $1.301K 156.4K

Buyers (Bids)

No. Vol. Price($)
27 6745374 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 1257781 6
View Market Depth
Last trade - 15.56pm 22/07/2025 (20 minute delay) ?

Top Stories

Fletcher Building 'exploring options' around construction division sale

Fletcher Building (ASX:FBU) is actively considering the sale of its under@performing construction division, including the Higgins, Brian Perry Civil, and Fletcher Construction Major Projects business units.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest he...
'Share long-term visions': Champion Iron rallies on mooted Nippon, Sojitz partnership Iron ore explorer Champion Iron (ASX:CIA) has spiked more than +4.2% in intra-day trade on Tuesday after signing a definitive framework agreement with Japan’s Nippon Steel Corporation and Sojitz Corporation to jointly develop the Kamistiatusset Iron Ore Project in Labrador, Canada...
Resolution Minerals appoints industry experts to fast-track US growth strategy Resolution Minerals (ASX:RML) has brought two highly respected mining executives on board to guide the company as market-focused senior strategic advisors as RML looks to crack the U.S. critical minerals sector.Listen to the HotCopper podcast for in-depth discussions and insights on all the bigge...
ASX Market Close: How a megadam in Tibet pushed us into the red Good Afternoon and welcome to HotCopper’s market close for Tuesday, I’m Jon Davidson. It was looking like a good day early morning...
Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist Welcome to this week’s HotCopperWire, our market watch podcast! Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through the week’s biggest news headlines @ and what they mean for Oz investors.In this Week 29 epis...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.